Gastrointestinal perforation historical perspective

Jump to navigation Jump to search

Gastrointestinal perforation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating gastrointestinal perforation from other diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gastrointestinal perforation historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gastrointestinal perforation historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gastrointestinal perforation historical perspective

CDC on Gastrointestinal perforation historical perspective

Gastrointestinal perforation historical perspective in the news

Blogs on Gastrointestinal perforation historical perspective

Directions to Hospitals Treating Stomach cancer

Risk calculators and risk factors for Gastrointestinal perforation historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]}; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]

Overview

Boerhaave syndrome was first described by the physician Herman Boerhaave, Professor of Medicine at Leiden University, in a publication entitled “History of a Grievous Disease Not Previously Described”. Hundred years ago, polish clinical researcher professor W.Jaworski was the first to describe the spiral-shaped microorganism at Cracow Jagiellonian University In 1586, Marcellus Donatus of Mantua described gastric ulcers by performing autopsies. In 1688, Johannes von Murault gave detailed description of duodenal ulcers. The appropriate therapy for intestinal perforation in typhoid fever has been controversial since the late 1880s.

Gastrointestinal perforation historical perspective

  • Boerhaave syndrome was first described by the physician Herman Boerhaave, Professor of Medicine at Leiden University, in a publication entitled “History of a Grievous Disease Not Previously Described”.[1]
  • Dr. Herman Boerhaave (1668-1738) described esophageal rupture and the subsequent mediastinal sepsis based upon his careful clinical and autopsy findings. Hundreds of references have since been written about Boerhaave's syndrome.[2]
  • Hundred years ago, polish clinical researcher professor W.Jaworski was the first to describe the spiral-shaped microorganism at Cracow Jagiellonian University
  • In 1586, Marcellus Donatus of Mantua described gastric ulcers by performing autopsies
  • In 1688, Johannes von Murault gave detailed description of duodenal ulcers.
  • In 1821, Nepveu found a relationship between gastritis and gastric cancer.
  • In 1875, G.Bottcher and M. Letulle hypothesize that ulcers are caused by bacteria.
  • In 1889, Walery Jaworski found spiral organisms in sediment washings of humans and proposed that these organisms may be involved with gastric disease.[3]
  • In late 1970, J.R Warren, a pathologist in Perth, Australia found the appearance of spiral bacteria overlying gastric mucosa.
  • In 1589, Dr. Hildanus was the first physician to discover diverticular lesion in the colon.[4]
  • In the 1700s, Alexis Littre was the first to describe diverticular diseases when he described a diverticular hernia.
  • In 1812, Dr. Meckel described the diverticulum now known as Meckel's diverticulum.
  • In 1902, Dr. Deetz provided a full description of infection of the diverticulum.
  • The appropriate therapy for intestinal perforation in typhoid fever has been controversial since the late 1880s.[5]
  • Around the turn of the century, surgery became the established mode of therapy, with a mortality of 69% based on 166 patients in the English-language medical literature, and continued to be the preferred treatment until the advent of chloramphenicol in 1948.

References

  1. Tamatey MN, Sereboe LA, Tettey MM, Entsua-Mensah K, Gyan B (2013). "Boerhaave's syndrome: diagnosis and successful primary repair one month after the oesophageal perforation". Ghana Med J. 47 (1): 53–5. PMC 3645189. PMID 23661858.
  2. Adams BD, Sebastian BM, Carter J (2006). "Honoring the Admiral: Boerhaave-van Wassenaer's syndrome". Dis Esophagus. 19 (3): 146–51. doi:10.1111/j.1442-2050.2006.00556.x. PMID 16722990.
  3. Konturek JW (2003). "Discovery by Jaworski of Helicobacter pylori and its pathogenetic role in peptic ulcer, gastritis and gastric cancer". J Physiol Pharmacol. 54 Suppl 3: 23–41. PMID 15075463.
  4. MOSES WR (1947). "Meckel's diverticulum; report of two unusual cases". N Engl J Med. 237 (4): 118–22. doi:10.1056/NEJM194707242370403. PMID 20252118.
  5. Bitar R, Tarpley J (1985). "Intestinal perforation in typhoid fever: a historical and state-of-the-art review". Rev Infect Dis. 7 (2): 257–71. PMID 3890098.

Template:WH Template:WS